ATHN - athenahealth Stock Price, News & Analysis

$130.23 -0.33 (-0.25 %)
(As of 11/24/2017 03:45 AM ET)
Previous Close$130.56
Today's Range$127.12 - $131.80
52-Week Range$90.11 - $158.66
Volume998,200 shs
Average Volume581,297 shs
Market Capitalization$5.21 billion
P/E Ratio110.36
Dividend YieldN/A
Beta1.57

About athenahealth (NASDAQ:ATHN)

athenahealth logoathenahealth, Inc. provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet. The Company has a range of network-enabled services to support healthcare providers across the continuum of care. The Company offers various combinations of its services to its clients, including athenaOne and athenaOne for Hospitals and Health Systems, depending on whether they are medical groups and practices or hospitals and larger health systems. As of December 31, 2016, the Company connected care across a national network of approximately 88,000 providers and approximately 86 million patients. Its suite of network-enabled services includes athenaCollector, athenaClinicals, athenaCommunicator, athenaCoordinator, Population Health and Epocrates.


Industry, Sector and Symbol

Industry Medical Software & Technology Services
Sub-IndustryHealth Care Technology
SectorMedical
SymbolNASDAQ:ATHN
CUSIP04685W10

Debt

Debt-to-Equity Ratio0.35%
Current Ratio1.67%
Quick Ratio1.67%

Price-To-Earnings

Trailing P/E Ratio110.36
Forward P/E Ratio112.27
P/E Growth5.04

Sales & Book Value

Annual Sales$1.08 billion
Price / Sales4.81
Cash Flow$4.67 per share
Price / Cash27.91
Book Value$18.62 per share
Price / Book6.99

Dividend

Annual DividendN/A
Dividend YieldN/A

Profitability

Trailing EPS$0.77
Net Income$21 million
Net Margins2.65%
Return on Equity6.78%
Return on Assets3.83%

Miscellaneous

Employees5,305
Outstanding Shares40,020,000

Frequently Asked Questions for athenahealth (NASDAQ:ATHN)

What is athenahealth's stock symbol?

athenahealth trades on the NASDAQ under the ticker symbol "ATHN."

How were athenahealth's earnings last quarter?

athenahealth, Inc. (NASDAQ:ATHN) posted its earnings results on Thursday, October, 19th. The health services provider reported $0.56 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.50 by $0.06. The health services provider had revenue of $304.60 million for the quarter, compared to analyst estimates of $310.52 million. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The business's quarterly revenue was up 10.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.60 EPS. View athenahealth's Earnings History.

When will athenahealth make its next earnings announcement?

athenahealth is scheduled to release their next quarterly earnings announcement on Monday, February, 5th 2018. View Earnings Estimates for athenahealth.

Where is athenahealth's stock going? Where will athenahealth's stock price be in 2017?

24 analysts have issued 1-year price targets for athenahealth's shares. Their predictions range from $88.00 to $186.00. On average, they anticipate athenahealth's share price to reach $141.77 in the next twelve months. View Analyst Ratings for athenahealth.

What are Wall Street analysts saying about athenahealth stock?

Here are some recent quotes from research analysts about athenahealth stock:

  • 1. Cantor Fitzgerald analysts commented, "This morning, athenaHealth filed an 8-K indicating that it implemented a change in control severance plan for certain executives." (10/27/2017)
  • 2. Canaccord Genuity analysts commented, "Date and time of first dissemination: October 27, 2017, 13:00 ET Date and time of production: October 27, 2017, 13:00 ET Target Price / Valuation Methodology: athenahealth – ATHN Our price target of of $123 is based on 3.8x 2018E sales. Risks to achieving Target Price / Valuation: athenahealth – ATHN Physician market consolidation could create headwinds if hospital acquisitions of physician groups shrink the physician office market. Our long-term thesis on athenahealth assumes the company is able to grow in the hospital market. If the company is unable to succeed in this market, our long-term thesis could be at risk. Any changes to reimbursement rates or regulatory changes could pose a risk to athenahealth’s customer base and their ability to collect payments; any such changes could negatively impact athenahealth’s revenue and profitability. Distribution of Ratings: Global Stock Ratings (as of 10/27/17) Rating Coverage Universe IB Clients # % % Buy 567 60.90% 39.68% Hold 252 27.07% 23.41% Sell 23 2.47% 17.39% Speculative Buy 89 9.56% 68.54% 931* 100.0% *Total includes stocks that are Under Review Canaccord Genuity Ratings System BUY: The stock is expected to generate risk-adjusted returns of over 10% during the next 12 months. HOLD: The stock is expected to generate risk-adjusted returns of 0-10% during the next 12 months. SELL: The stock is expected to generate negative risk-adjusted returns during the next 12 months. NOT RATED: Canaccord Genuity does not provide research coverage of the relevant issuer." (10/23/2017)
  • 3. Piper Jaffray Companies analysts commented, "We have updated our model and estimates to reflect the new company presentation. We have slightly lowered our PT to $160 from $162 to reflect our revised estimates. Despite this we remain confident in the company's FY17 outlook, and would be buying shares at current market valuation. Reiterate OW, PT $160." (2/7/2017)
  • 4. Stifel Nicolaus analysts commented, "ATHN reported 4Q EPS after the close 2/2/17 with a call at 8am ET this morning. Revenue ($288.2mn) was 5% ($17mn) below consensus and guidance, while EPS of $0.62 exceeded consensus ($0.51). Management reiterated 2017 revenue, bookings and adjusted operating income guidance; however, with the revenue miss revenue growth must reaccelerate more than previously expected and margins must improve less." (2/6/2017)

Who are some of athenahealth's key competitors?

Who are athenahealth's key executives?

athenahealth's management team includes the folowing people:

  • Jonathan S. Bush, Chairman of the Board, President, Chief Executive Officer (Age 48)
  • John A. Kane, Interim Chief Financial Officer, Principal Accounting Officer, Principal Financial Officer, Director (Age 64)
  • Prakash Khot, Senior Vice President, Chief Technology Officer (Age 47)
  • Timothy O'Brien, Senior Vice President, Chief Marketing Officer (Age 41)
  • Dan Haley, Senior Vice President, General Counsel, Secretary (Age 44)
  • Kyle Armbrester, Senior Vice President, Chief Product Officer (Age 32)
  • Brandon H. Hull, Lead Independent Director (Age 56)
  • Brian P. McKeon, Director (Age 54)
  • Thomas J. Szkutak, Director (Age 56)
  • Amy Abernethy M.D. Ph.D., Independent Director (Age 48)

Who owns athenahealth stock?

athenahealth's stock is owned by many different of retail and institutional investors. Top institutional investors include Janus Henderson Group PLC (11.65%), Riverbridge Partners LLC (2.46%), Jackson Square Partners LLC (1.31%), Allianz Asset Management GmbH (0.83%), Bank of New York Mellon Corp (0.82%) and Sumitomo Mitsui Asset Management Company LTD (0.81%). Company insiders that own athenahealth stock include Amy Abernethy, Bradford Kyle Armbrester, Brandon H Hull, Daniel P Haley, Ed Park, John A Kane, Jonathan Bush, Jonathan D Porter, Karl Stubelis, Kristi Ann Matus and Timothy John O'brien. View Institutional Ownership Trends for athenahealth.

Who sold athenahealth stock? Who is selling athenahealth stock?

athenahealth's stock was sold by a variety of institutional investors in the last quarter, including Artisan Partners Limited Partnership, Janus Henderson Group PLC, Sumitomo Mitsui Asset Management Company LTD, Ruane Cunniff & Goldfarb Inc., Allianz Asset Management GmbH, Pictet Asset Management Ltd., Riverbridge Partners LLC and Scout Investments Inc.. Company insiders that have sold athenahealth company stock in the last year include Amy Abernethy, Bradford Kyle Armbrester, Brandon H Hull, Daniel P Haley, Ed Park, John A Kane, Jonathan Bush, Jonathan D Porter and Karl Stubelis. View Insider Buying and Selling for athenahealth.

Who bought athenahealth stock? Who is buying athenahealth stock?

athenahealth's stock was purchased by a variety of institutional investors in the last quarter, including Jackson Square Partners LLC, Sumitomo Mitsui Trust Holdings Inc., First Trust Advisors LP, Toronto Dominion Bank, Perceptive Advisors LLC, Sei Investments Co., Stevens Capital Management LP and Macquarie Group Ltd.. View Insider Buying and Selling for athenahealth.

How do I buy athenahealth stock?

Shares of athenahealth can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is athenahealth's stock price today?

One share of athenahealth stock can currently be purchased for approximately $130.23.

How big of a company is athenahealth?

athenahealth has a market capitalization of $5.21 billion and generates $1.08 billion in revenue each year. The health services provider earns $21 million in net income (profit) each year or $0.77 on an earnings per share basis. athenahealth employs 5,305 workers across the globe.

How can I contact athenahealth?

athenahealth's mailing address is 311 ARSENAL STREET, WATERTOWN MA, 02472. The health services provider can be reached via phone at 617-402-1000 or via email at [email protected]


MarketBeat Community Rating for athenahealth (ATHN)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  472 (Vote Outperform)
Underperform Votes:  547 (Vote Underperform)
Total Votes:  1,019
MarketBeat's community ratings are surveys of what our community members think about athenahealth and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for athenahealth (NASDAQ:ATHN)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 13 Hold Ratings, 10 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Hold (Score: 2.38)
Consensus Price Target: $141.77 (8.86% upside)

Consensus Price Target History for athenahealth (NASDAQ:ATHN)

Price Target History for athenahealth (NASDAQ:ATHN)

Analysts' Ratings History for athenahealth (NASDAQ:ATHN)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/27/2017Cantor FitzgeraldReiterated RatingHold$120.00N/AView Rating Details
10/25/2017SunTrust Banks, Inc.Reiterated RatingBuy$156.00N/AView Rating Details
10/23/2017Leerink SwannLower Price TargetMarket Perform$155.00 -> $125.00N/AView Rating Details
10/23/2017Wells Fargo & CoLower Price TargetOutperform$190.00 -> $155.00N/AView Rating Details
10/23/2017Canaccord GenuityReiterated RatingHold$144.00 -> $123.00N/AView Rating Details
10/23/2017First AnalysisUpgradeUnderweight -> Equal Weight$125.00 -> $127.00N/AView Rating Details
10/22/2017Robert W. BairdLower Price TargetOutperform$170.00 -> $155.00N/AView Rating Details
10/20/2017Royal Bank Of CanadaSet Price TargetHold$144.00N/AView Rating Details
10/20/2017Oppenheimer Holdings, Inc.Reiterated RatingBuy$184.00N/AView Rating Details
10/20/2017KeyCorpLower Price TargetOverweight$170.00 -> $140.00N/AView Rating Details
10/17/2017Piper Jaffray CompaniesReiterated RatingBuy$167.00N/AView Rating Details
10/13/2017Jefferies Group LLCSet Price TargetHold$120.00 -> $110.00N/AView Rating Details
8/2/2017Morgan StanleyReiterated RatingEqual Weight$108.00 -> $125.00LowView Rating Details
7/31/2017Cowen IncDowngradeOutperform -> Market Perform$127.00 -> $133.00MediumView Rating Details
7/24/2017Citigroup Inc.Reiterated RatingBuy$169.00 -> $186.00LowView Rating Details
7/22/2017Evercore ISIReiterated RatingOutperform$155.00 -> $163.00LowView Rating Details
7/21/2017William BlairReiterated RatingMarket PerformMediumView Rating Details
7/19/2017J P Morgan Chase & CoSet Price TargetHold$136.00LowView Rating Details
7/7/2017Dougherty & CoDowngradeBuy -> NeutralHighView Rating Details
7/7/2017ArgusInitiated CoverageHoldHighView Rating Details
6/16/2017Stifel NicolausReiterated RatingHold$106.00 -> $151.00LowView Rating Details
5/1/2017Barclays PLCSet Price TargetUnderweight$97.00 -> $88.00MediumView Rating Details
2/7/2017Berenberg BankInitiated CoverageBuy$143.00N/AView Rating Details
1/4/2017Pacific CrestUpgradeOverweight$140.00N/AView Rating Details
7/22/2016FBR & CoLower Price TargetMarket Perform$145.00 -> $140.00N/AView Rating Details
7/22/2016Deutsche Bank AGDowngradeBuy -> Hold$165.00 -> $147.00N/AView Rating Details
2/8/2016Goldman Sachs Group, Inc. (The)Lower Price TargetNeutral$155.00 -> $149.00N/AView Rating Details
2/8/2016Topeka Capital MarketsUpgradeHold -> Buy$169.00 -> $160.00N/AView Rating Details
(Data available from 11/24/2015 forward)

Earnings

Earnings History and Estimates Chart for athenahealth (NASDAQ:ATHN)

Earnings by Quarter for athenahealth (NASDAQ:ATHN)

Earnings History by Quarter for athenahealth (NASDAQ ATHN)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/5/2018$0.63N/AView Earnings Details
10/19/2017Q3 2017$0.50$0.56$310.52 million$304.60 millionViewN/AView Earnings Details
7/20/2017Q2 2017$0.39$0.51$298.68 million$301.10 millionViewN/AView Earnings Details
4/27/2017Q1 2017$0.11$0.10$296.49 million$285.40 millionViewN/AView Earnings Details
2/2/2017Q4 2016$0.51$0.62$303.72 million$288.20 millionViewListenView Earnings Details
10/20/2016Q3$0.47$0.60$280.17 million$276.67 millionViewListenView Earnings Details
7/21/2016Q2$0.42$0.34$274.07 million$261.90 millionViewListenView Earnings Details
4/28/2016Q1$0.26$0.34$248.49 million$256.15 millionViewListenView Earnings Details
2/4/2016Q415$0.41$0.45$257.68 million$257.50 millionViewN/AView Earnings Details
10/22/2015Q315$0.26$0.36$233.03 million$236.10 millionViewListenView Earnings Details
7/23/2015Q215$0.25$0.32$227.08 million$224.70 millionViewListenView Earnings Details
4/30/2015Q115($0.10)$0.24$205.24 million$206.40 millionViewListenView Earnings Details
2/5/2015Q414$0.39$0.58$207.99 million$213.20 millionViewN/AView Earnings Details
10/16/2014Q314$0.27$0.27$190.40 million$190.40 millionViewListenView Earnings Details
7/17/2014Q214$0.22$0.32$182.14 million$185.90 millionViewN/AView Earnings Details
4/17/2014Q114($0.01)$0.12$170.03 million$163.00 millionViewListenView Earnings Details
2/6/2014Q413$0.45$0.57$168.39 million$171.60 millionViewN/AView Earnings Details
10/17/2013Q313$0.31$0.29$154.80 million$151.50 millionViewN/AView Earnings Details
7/18/2013Q2 2013$0.22($0.08)$148.24 million$149.30 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.23$0.38$121.05 million$125.60 millionViewListenView Earnings Details
2/7/2013Q4 2012$0.28$0.29$116.97 million$116.30 millionViewListenView Earnings Details
10/18/2012$0.26$0.30ViewN/AView Earnings Details
7/19/2012$0.23$0.24ViewN/AView Earnings Details
4/26/2012$0.17$0.17ViewN/AView Earnings Details
2/15/2012$0.23$0.26ViewN/AView Earnings Details
10/20/2011$0.20$0.24ViewN/AView Earnings Details
7/21/2011$0.19$0.22ViewN/AView Earnings Details
4/28/2011$0.13$0.17ViewN/AView Earnings Details
2/17/2011$0.20$0.28ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for athenahealth (NASDAQ:ATHN)
2017 EPS Consensus Estimate: $1.16
2018 EPS Consensus Estimate: $1.41
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.17$0.28$0.23
Q2 20172$0.06$0.34$0.20
Q3 20173$0.20$0.36$0.27
Q4 20172$0.42$0.50$0.46
Q1 20181$0.22$0.22$0.22
Q2 20181$0.33$0.33$0.33
Q3 20181$0.34$0.34$0.34
Q4 20181$0.52$0.52$0.52
(Data provided by Zacks Investment Research)

Dividends

Dividend History for athenahealth (NASDAQ:ATHN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for athenahealth (NASDAQ ATHN)

Insider Ownership Percentage: 3.20%
Insider Trades by Quarter for athenahealth (NASDAQ:ATHN)
Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Insider Trades by Quarter for athenahealth (NASDAQ ATHN)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/20/2017Brandon H. HullDirectorSell800$130.00$104,000.00View SEC Filing  
10/27/2017Bradford Kyle ArmbresterSVPSell1,000$128.56$128,560.00View SEC Filing  
10/20/2017Brandon H. HullDirectorSell800$130.00$104,000.00View SEC Filing  
10/2/2017Daniel P HaleyInsiderSell1,583$124.56$197,178.48View SEC Filing  
10/2/2017Jonathan BushCEOSell4,000$124.17$496,680.00View SEC Filing  
9/15/2017Jonathan D. PorterSVPSell300$130.38$39,114.00View SEC Filing  
9/1/2017Brandon H. HullDirectorSell800$140.95$112,760.00View SEC Filing  
9/1/2017Jonathan BushCEOSell4,000$139.77$559,080.00View SEC Filing  
8/15/2017Jonathan D. PorterSVPSell300$142.88$42,864.00View SEC Filing  
8/1/2017Brandon H. HullDirectorSell800$140.01$112,008.00View SEC Filing  
8/1/2017Jonathan BushCEOSell4,000$143.31$573,240.00View SEC Filing  
7/21/2017Jonathan D. PorterSVPSell422$154.00$64,988.00View SEC Filing  
7/17/2017Jonathan D. PorterSVPSell300$143.13$42,939.00View SEC Filing  
7/3/2017Brandon H. HullDirectorSell800$140.81$112,648.00View SEC Filing  
7/3/2017Jonathan BushCEOSell4,000$140.52$562,080.00View SEC Filing  
6/15/2017Jonathan D. PorterSVPSell300$142.27$42,681.00View SEC Filing  
6/5/2017Karl StubelisCFOSell3,952$138.98$549,248.96View SEC Filing  
5/18/2017Bradford Kyle ArmbresterSVPSell2,431$130.00$316,030.00View SEC Filing  
5/18/2017Brandon H. HullDirectorSell1,600$130.00$208,000.00View SEC Filing  
5/18/2017Jonathan BushCEOSell4,000$125.85$503,400.00View SEC Filing  
5/15/2017Jonathan D. PorterSVPSell300$109.48$32,844.00View SEC Filing  
4/25/2017Jonathan BushCEOSell8,000$120.00$960,000.00View SEC Filing  
1/27/2017John A KaneDirectorSell2,875$123.11$353,941.25View SEC Filing  
1/12/2017Jonathan BushCEOSell4,000$120.00$480,000.00View SEC Filing  
12/15/2016Amy AbernethyDirectorSell1,000$117.15$117,150.00View SEC Filing  
12/15/2016Ed ParkCOOSell2,500$117.15$292,875.00View SEC Filing  
12/15/2016Jonathan BushCEOSell8,000$120.00$960,000.00View SEC Filing  
12/1/2016Ed ParkCOOSell1,500$94.60$141,900.00View SEC Filing  
10/27/2016John A. KaneDirectorSell5,750$122.63$705,122.50View SEC Filing  
10/10/2016Bradford Kyle ArmbresterSVPSell2,545$130.00$330,850.00View SEC Filing  
10/10/2016Brandon H HullDirectorSell2,400$130.00$312,000.00View SEC Filing  
10/3/2016Daniel P HaleySVPSell2,109$124.43$262,422.87View SEC Filing  
10/3/2016Jonathan BushCEOSell4,000$124.34$497,360.00View SEC Filing  
9/7/2016Karl StubelisVPSell928$123.36$114,478.08View SEC Filing  
8/15/2016Ed ParkCOOSell4,000$124.20$496,800.00View SEC Filing  
8/1/2016Jonathan BushCEOSell4,000$128.19$512,760.00View SEC Filing  
7/27/2016John A KaneDirectorSell2,875$128.81$370,328.75View SEC Filing  
7/6/2016Ed ParkCOOSell1,500$136.85$205,275.00View SEC Filing  
7/1/2016Brandon H HullDirectorSell800$137.48$109,984.00View SEC Filing  
7/1/2016Jonathan BushCEOSell4,000$138.21$552,840.00View SEC Filing  
6/2/2016Brandon H HullDirectorSell800$130.00$104,000.00View SEC Filing  
6/1/2016Ed ParkCOOSell1,500$125.82$188,730.00View SEC Filing  
6/1/2016Jonathan BushCEOSell4,000$125.97$503,880.00View SEC Filing  
5/4/2016Ed ParkCOOSell1,500$127.81$191,715.00View SEC Filing  
5/2/2016Brandon H HullDirectorSell800$132.74$106,192.00View SEC Filing  
5/2/2016Jonathan BushCEOSell4,000$132.09$528,360.00View SEC Filing  
5/2/2016Kristi Ann MatusEVPSell415$133.27$55,307.05View SEC Filing  
4/25/2016Karl StubelisVPSell547$138.64$75,836.08View SEC Filing  
4/6/2016Ed ParkCOOSell1,500$139.15$208,725.00View SEC Filing  
4/1/2016Brandon H HullDirectorSell800$137.72$110,176.00View SEC Filing  
4/1/2016Jonathan BushCEOSell4,000$138.44$553,760.00View SEC Filing  
4/1/2016Kristi Ann MatusEVPSell415$138.61$57,523.15View SEC Filing  
3/3/2016Bradford Kyle ArmbresterSVPSell1,369$132.04$180,762.76View SEC Filing  
3/1/2016Brandon H HullDirectorSell1,600$130.00$208,000.00View SEC Filing  
3/1/2016Daniel P HaleySVPSell1,279$130.64$167,088.56View SEC Filing  
3/1/2016Ed ParkCOOSell1,500$131.66$197,490.00View SEC Filing  
3/1/2016Jonathan BushCEOSell4,000$129.61$518,440.00View SEC Filing  
3/1/2016Kristi Ann MatusEVPSell415$129.53$53,754.95View SEC Filing  
3/1/2016Timothy John O'brienCMOSell846$132.25$111,883.50View SEC Filing  
2/16/2016Bradford Kyle ArmbresterSVPSell1,657$127.11$210,621.27View SEC Filing  
2/16/2016Timothy John O'brienCMOSell816$127.08$103,697.28View SEC Filing  
2/3/2016Ed ParkCOOSell1,500$140.61$210,915.00View SEC Filing  
2/1/2016Jonathan BushCEOSell4,000$140.14$560,560.00View SEC Filing  
2/1/2016Kristi Ann MatusEVPSell415$141.08$58,548.20View SEC Filing  
1/27/2016John A. KaneDirectorSell2,875$140.81$404,828.75View SEC Filing  
1/6/2016Ed ParkCOOSell1,500$161.89$242,835.00View SEC Filing  
1/4/2016Jonathan BushCEOSell4,000$156.79$627,160.00View SEC Filing  
1/4/2016Kristi Ann MatusEVPSell415$159.06$66,009.90View SEC Filing  
12/2/2015Ed ParkCOOSell1,500$166.81$250,215.00View SEC Filing  
11/20/2015Stephen N KahaneEVPSell1,280$157.80$201,984.00View SEC Filing  
11/6/2015Stephen N KahaneEVPSell5,000$159.51$797,550.00View SEC Filing  
11/4/2015Ed ParkCOOSell1,500$162.32$243,480.00View SEC Filing  
11/3/2015Jonathan BushCEOSell14,750$156.50$2,308,375.00View SEC Filing  
10/27/2015John A. KaneDirectorSell2,875$150.44$432,515.00View SEC Filing  
10/23/2015Jonathan BushCEOSell20,000$157.50$3,150,000.00View SEC Filing  
10/23/2015Robert CosinukeCMOSell1,211$159.02$192,573.22View SEC Filing  
10/23/2015Stephen N KahaneEVPSell5,000$150.50$752,500.00View SEC Filing  
10/20/2015Stephen N KahaneEVPSell2,000$132.88$265,760.00View SEC Filing  
10/7/2015Ed ParkCOOSell1,500$134.23$201,345.00View SEC Filing  
10/2/2015Jonathan BushCEOSell1,000$130.74$130,740.00View SEC Filing  
9/15/2015Stephen N KahaneEVPSell2,000$135.77$271,540.00View SEC Filing  
9/2/2015Ed ParkCOOSell1,500$129.64$194,460.00View SEC Filing  
9/2/2015Jonathan BushCEOSell1,000$131.09$131,090.00View SEC Filing  
8/18/2015Stephen N KahaneEVPSell2,000$141.49$282,980.00View SEC Filing  
7/24/2015David Eric RobinsonDirectorSell10,000$130.00$1,300,000.00View SEC Filing  
7/21/2015Stephen N KahaneEVPSell2,000$117.32$234,640.00View SEC Filing  
7/2/2015Jonathan BushCEOSell1,000$114.17$114,170.00View SEC Filing  
6/2/2015Jonathan BushCEOSell1,000$115.32$115,320.00View SEC Filing  
4/27/2015John A KaneDirectorSell2,875$125.35$360,381.25View SEC Filing  
4/14/2015Karl StubelisVPSell1,115$126.28$140,802.20View SEC Filing  
4/2/2015Jonathan BushCEOSell1,000$118.77$118,770.00View SEC Filing  
3/10/2015James L MannDirectorSell13,106$121.27$1,589,364.62View SEC Filing  
3/3/2015Robert CosinukeCMOSell6,000$128.15$768,900.00View SEC Filing  
2/24/2015Jonathan BushCEOSell2,499$130.23$325,444.77View SEC Filing  
2/18/2015Jonathan BushCEOSell2,498$132.04$329,835.92View SEC Filing  
2/10/2015Jonathan BushCEOSell7,495$135.82$1,017,970.90View SEC Filing  
2/5/2015David Eric RobinsonDirectorSell25,000$143.17$3,579,250.00View SEC Filing  
2/3/2015Robert CosinukeCMOSell6,000$139.06$834,360.00View SEC Filing  
1/5/2015David Eric RobinsonDirectorSell25,000$145.14$3,628,500.00View SEC Filing  
1/5/2015Robert CosinukeCMOSell6,000$145.18$871,080.00View SEC Filing  
12/22/2014Robert CosinukeCMOSell6,000$139.32$835,920.00View SEC Filing  
12/2/2014Jonathan BushCEOSell1,000$116.55$116,550.00View SEC Filing  
10/10/2014Robert CosinukeCMOSell3,000$123.78$371,340.00View SEC Filing  
10/2/2014Jonathan BushCEOSell1,000$128.41$128,410.00View SEC Filing  
9/10/2014Robert CosinukeCMOSell6,000$138.08$828,480.00View SEC Filing  
8/11/2014Robert CosinukeCMOSell6,000$129.43$776,580.00View SEC Filing  
8/4/2014Jonathan BushCEOSell1,000$121.58$121,580.00View SEC Filing  
7/10/2014Robert CosinukeCMOSell6,000$120.10$720,600.00View SEC Filing  
7/2/2014Jonathan BushCEOSell1,000$129.45$129,450.00View SEC Filing  
7/1/2014Stephen N KahaneInsiderSell5,000$127.60$638,000.00View SEC Filing  
6/12/2014David Eric RobinsonDirectorSell30,000$124.12$3,723,600.00View SEC Filing  
6/10/2014Robert CosinukeCMOSell6,000$125.07$750,420.00View SEC Filing  
6/2/2014Jonathan BushCEOSell1,000$125.82$125,820.00View SEC Filing  
6/2/2014Stephen N KahaneInsiderSell5,000$126.42$632,100.00View SEC Filing  
5/2/2014Jonathan BushCEOSell1,000$123.21$123,210.00View SEC Filing  
5/1/2014Stephen KahaneInsiderSell5,000$121.96$609,800.00View SEC Filing  
4/16/2014Stephen KahaneInsiderSell10,000$143.96$1,439,600.00View SEC Filing  
4/14/2014David Eric RobinsonDirectorSell60,000$140.61$8,436,600.00View SEC Filing  
4/10/2014Robert CosinukeCMOSell6,000$151.14$906,840.00View SEC Filing  
4/2/2014Jonathan BushCEOSell1,000$161.74$161,740.00View SEC Filing  
3/10/2014Robert CosinukeCMOSell6,000$181.60$1,089,600.00View SEC Filing  
2/18/2014Timothy AdamsCFOSell30,000$194.58$5,837,400.00View SEC Filing  
2/12/2014Dev IttycheriaDirectorSell2,000$181.17$362,340.00View SEC Filing  
2/10/2014Robert CosinukeCMOSell6,000$172.72$1,036,320.00View SEC Filing  
2/3/2014Daniel OrensteinSVPSell1,000$146.73$146,730.00View SEC Filing  
2/3/2014David Eric RobinsonDirectorSell4,000$146.86$587,440.00View SEC Filing  
1/10/2014Robert CosinukeCMOSell6,000$132.92$797,520.00View SEC Filing  
1/3/2014David Eric RobinsonDirectorSell4,000$131.86$527,440.00View SEC Filing  
12/10/2013Robert CosinukeCMOSell6,000$132.77$796,620.00View SEC Filing  
12/3/2013David Eric RobinsonDirectorSell4,000$132.48$529,920.00View SEC Filing  
12/2/2013Jonathan BushCEOSell1,000$132.24$132,240.00View SEC Filing  
11/4/2013David Eric RobinsonDirectorSell4,000$137.26$549,040.00View SEC Filing  
11/4/2013Jonathan BushCEOSell1,000$137.26$137,260.00View SEC Filing  
11/1/2013Daniel H OrensteinSVPSell1,000$133.15$133,150.00View SEC Filing  
10/21/2013Timothy M AdamsCFOSell20,000$138.39$2,767,800.00View SEC Filing  
10/18/2013Ed ParkCOOSell10,021$123.36$1,236,190.56View SEC Filing  
10/18/2013Jonathan BushCEOSell20,000$120.00$2,400,000.00View SEC Filing  
10/10/2013Robert CosinukeCMOSell6,000$108.21$649,260.00View SEC Filing  
10/3/2013David Eric RobinsonDirectorSell4,000$111.01$444,040.00View SEC Filing  
10/2/2013Jonathan BushCEOSell1,000$110.16$110,160.00View SEC Filing  
9/10/2013Robert CosinukeCMOSell6,000$109.68$658,080.00View SEC Filing  
9/3/2013Daniel OrensteinSVPSell1,000$106.73$106,730.00View SEC Filing  
9/3/2013David Eric RobinsonDirectorSell4,000$106.53$426,120.00View SEC Filing  
9/3/2013Jonathan BushCEOSell22,105$106.45$2,353,077.25View SEC Filing  
8/19/2013John KaneDirectorSell2,000$111.23$222,460.00View SEC Filing  
8/15/2013John KaneDirectorSell5,000$110.03$550,150.00View SEC Filing  
8/12/2013Robert CosinukeCMOSell6,000$115.72$694,320.00View SEC Filing  
8/5/2013David Eric RobinsonDirectorSell4,000$114.01$456,040.00View SEC Filing  
8/1/2013Daniel H OrensteinSVPSell1,000$113.73$113,730.00View SEC Filing  
8/1/2013Jonathan BushCEOSell5,000$113.94$569,700.00View SEC Filing  
7/12/2013Timothy M AdamsCFOSell10,000$106.14$1,061,400.00View SEC Filing  
7/11/2013David Eric RobinsonDirectorSell4,000$90.00$360,000.00View SEC Filing  
7/10/2013Robert CosinukeCMOSell6,000$87.06$522,360.00View SEC Filing  
7/1/2013Daniel H OrensteinSVPSell1,000$85.01$85,010.00View SEC Filing  
7/1/2013Jonathan BushCEOSell5,000$85.39$426,950.00View SEC Filing  
6/17/2013David Eric RobinsonDirectorSell4,000$90.00$360,000.00View SEC Filing  
6/10/2013Robert CosinukeCMOSell6,000$85.74$514,440.00View SEC Filing  
6/3/2013Daniel H OrensteinSVPSell1,000$84.22$84,220.00View SEC Filing  
6/3/2013Jonathan BushCEOSell5,000$84.39$421,950.00View SEC Filing  
5/10/2013Robert CosinukeCMOSell6,000$84.80$508,800.00View SEC Filing  
5/1/2013Jonathan BushCEOSell5,000$95.70$478,500.00View SEC Filing  
2/26/2013David Eric RobinsonDirectorSell10,000$90.13$901,300.00View SEC Filing  
8/10/2012Robert CosinukeCMOSell3,000$92.35$277,050.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for athenahealth (NASDAQ ATHN)

Source:
DateHeadline
athenahealth (ATHN) a Buy on Superior Earnings Momentum - Investorplace.comathenahealth (ATHN) a Buy on Superior Earnings Momentum - Investorplace.com
investorplace.com - November 23 at 3:38 PM
athenahealth (ATHN) a Buy on Superior Earnings Momentumathenahealth (ATHN) a Buy on Superior Earnings Momentum
investorplace.com - November 23 at 12:56 PM
Why Is athenahealth (ATHN) Up 10.7% Since the Last Earnings Report? - NasdaqWhy Is athenahealth (ATHN) Up 10.7% Since the Last Earnings Report? - Nasdaq
www.nasdaq.com - November 22 at 9:48 PM
Insider Selling: athenahealth, Inc. (ATHN) Director Sells 800 Shares of StockInsider Selling: athenahealth, Inc. (ATHN) Director Sells 800 Shares of Stock
www.americanbankingnews.com - November 21 at 4:38 PM
Why Is athenahealth (ATHN) Up 10.7% Since the Last Earnings Report?Why Is athenahealth (ATHN) Up 10.7% Since the Last Earnings Report?
finance.yahoo.com - November 20 at 5:26 PM
athenahealth (ATHN) a Buy on Superior Earnings Visibility - Investorplace.comathenahealth (ATHN) a Buy on Superior Earnings Visibility - Investorplace.com
investorplace.com - November 17 at 10:00 AM
athenahealth (ATHN) a Buy on Superior Earnings Visibilityathenahealth (ATHN) a Buy on Superior Earnings Visibility
investorplace.com - November 16 at 12:51 PM
Better Buy: Veeva Systems Inc vs. Athenahealth, IncBetter Buy: Veeva Systems Inc vs. Athenahealth, Inc
www.fool.com - November 15 at 5:55 PM
athenahealth, Inc. breached its 50 day moving average in a Bullish Manner : ATHN-US : November 9, 2017athenahealth, Inc. breached its 50 day moving average in a Bullish Manner : ATHN-US : November 9, 2017
finance.yahoo.com - November 9 at 5:19 PM
Rating on athenahealth (ATHN) Raised to Buy From a HoldRating on athenahealth (ATHN) Raised to Buy From a Hold
investorplace.com - November 9 at 3:38 PM
Zacks: Analysts Anticipate athenahealth, Inc. (ATHN) Will Announce Quarterly Sales of $323.37 MillionZacks: Analysts Anticipate athenahealth, Inc. (ATHN) Will Announce Quarterly Sales of $323.37 Million
www.americanbankingnews.com - November 8 at 4:30 AM
$0.62 Earnings Per Share Expected for athenahealth, Inc. (ATHN) This Quarter$0.62 Earnings Per Share Expected for athenahealth, Inc. (ATHN) This Quarter
www.americanbankingnews.com - November 6 at 9:22 PM
ETFs with exposure to athenahealth, Inc. : November 6, 2017ETFs with exposure to athenahealth, Inc. : November 6, 2017
finance.yahoo.com - November 6 at 3:49 PM
Analytics for Quant Score Drive Ranking of athenahealth (ATHN) to Buy - Investorplace.comAnalytics for Quant Score Drive Ranking of athenahealth (ATHN) to Buy - Investorplace.com
www.investorplace.com - November 2 at 4:45 PM
athenahealth, Inc. (ATHN) Given Consensus Rating of "Hold" by Analystsathenahealth, Inc. (ATHN) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - November 2 at 2:10 PM
Analytics for Quant Score Drive Ranking of athenahealth (ATHN) to BuyAnalytics for Quant Score Drive Ranking of athenahealth (ATHN) to Buy
investorplace.com - November 2 at 1:19 PM
athenahealth (ATHN) and Veeva Systems (VEEV) Head to Head Comparisonathenahealth (ATHN) and Veeva Systems (VEEV) Head to Head Comparison
www.americanbankingnews.com - November 1 at 3:22 PM
Watch CNBC's full interview with Athenahealth CEO Jonatha...Watch CNBC's full interview with Athenahealth CEO Jonatha...
finance.yahoo.com - October 31 at 4:03 PM
Athenahealth CEO Jonathan Bush: CVS-Aetna deal could be a...Athenahealth CEO Jonathan Bush: CVS-Aetna deal could be a...
finance.yahoo.com - October 31 at 4:03 PM
athenahealth, Inc. (ATHN) SVP Sells $128,560.00 in Stockathenahealth, Inc. (ATHN) SVP Sells $128,560.00 in Stock
www.americanbankingnews.com - October 31 at 11:26 AM
athenahealth, Inc. breached its 50 day moving average in a Bullish Manner : ATHN-US : October 30, 2017athenahealth, Inc. breached its 50 day moving average in a Bullish Manner : ATHN-US : October 30, 2017
finance.yahoo.com - October 30 at 5:08 PM
athenahealth, Inc. (ATHN) Rating Reiterated by Cantor Fitzgeraldathenahealth, Inc. (ATHN) Rating Reiterated by Cantor Fitzgerald
www.americanbankingnews.com - October 28 at 6:46 PM
Weak Earnings Growth Penalizes athenahealth (ATHN) Rating - Investorplace.comWeak Earnings Growth Penalizes athenahealth (ATHN) Rating - Investorplace.com
investorplace.com - October 28 at 4:18 AM
Earnings Review and Free Research Report: athenahealth Reported Better Than Expected Earnings ResultsEarnings Review and Free Research Report: athenahealth Reported Better Than Expected Earnings Results
finance.yahoo.com - October 27 at 6:16 PM
SunTrust Banks Comments on athenahealth, Inc.s FY2017 Earnings (ATHN)SunTrust Banks Comments on athenahealth, Inc.'s FY2017 Earnings (ATHN)
www.americanbankingnews.com - October 27 at 9:32 AM
Weak Earnings Growth Penalizes athenahealth (ATHN) RatingWeak Earnings Growth Penalizes athenahealth (ATHN) Rating
investorplace.com - October 26 at 1:24 PM
Athenahealth axes Atlanta workforce in $100 million cost restructuring (Video)Athenahealth axes Atlanta workforce in $100 million cost restructuring (Video)
finance.yahoo.com - October 25 at 5:22 PM
athenahealth (ATHN) vs. Evolent Health (EVH) Financial Contrastathenahealth (ATHN) vs. Evolent Health (EVH) Financial Contrast
www.americanbankingnews.com - October 25 at 7:12 AM
athenahealth, Inc. (ATHN) Director Sells $104,000.00 in Stockathenahealth, Inc. (ATHN) Director Sells $104,000.00 in Stock
www.americanbankingnews.com - October 24 at 7:38 PM
ETFs with exposure to athenahealth, Inc. : October 23, 2017ETFs with exposure to athenahealth, Inc. : October 23, 2017
finance.yahoo.com - October 23 at 5:09 PM
Wells Fargo & Company Trims athenahealth, Inc. (ATHN) Target Price to $155.00Wells Fargo & Company Trims athenahealth, Inc. (ATHN) Target Price to $155.00
www.americanbankingnews.com - October 23 at 4:24 PM
athenahealth, Inc. (ATHN) PT Lowered to $125.00athenahealth, Inc. (ATHN) PT Lowered to $125.00
www.americanbankingnews.com - October 23 at 4:24 PM
athenahealth, Inc. (ATHN) Stock Rating Reaffirmed by Canaccord Genuityathenahealth, Inc. (ATHN) Stock Rating Reaffirmed by Canaccord Genuity
www.americanbankingnews.com - October 23 at 9:22 AM
athenahealth (ATHN) & Its Rivals Critical Analysisathenahealth (ATHN) & Its Rivals Critical Analysis
www.americanbankingnews.com - October 23 at 12:08 AM
athenahealths (ATHN) "Buy" Rating Reiterated at Robert W. Bairdathenahealth's (ATHN) "Buy" Rating Reiterated at Robert W. Baird
www.americanbankingnews.com - October 22 at 8:22 AM
Shares of Activist Target AthenaHealth Rise After Q3 Results - TheStreet.comShares of Activist Target AthenaHealth Rise After Q3 Results - TheStreet.com
www.thestreet.com - October 22 at 1:57 AM
athenahealth, Inc. (ATHN) Stock Rating Reaffirmed by Cantor Fitzgeraldathenahealth, Inc. (ATHN) Stock Rating Reaffirmed by Cantor Fitzgerald
www.americanbankingnews.com - October 21 at 11:52 PM
Athenahealth cuts 9 percent of jobs companywide, affecting Austin and other satellite officesAthenahealth cuts 9 percent of jobs companywide, affecting Austin and other satellite offices
www.bizjournals.com - October 21 at 3:54 PM
Athenahealth cuts 9 percent of jobs companywide, affecting Austin and other satellite officesAthenahealth cuts 9 percent of jobs companywide, affecting Austin and other satellite offices
www.bizjournals.com - October 21 at 3:54 PM
Edited Transcript of ATHN earnings conference call or presentation 20-Oct-17 12:00pm GMTEdited Transcript of ATHN earnings conference call or presentation 20-Oct-17 12:00pm GMT
finance.yahoo.com - October 21 at 3:54 PM
Edited Transcript of ATHN earnings conference call or presentation 20-Oct-17 12:00pm GMTEdited Transcript of ATHN earnings conference call or presentation 20-Oct-17 12:00pm GMT
finance.yahoo.com - October 21 at 3:54 PM
Shares of Activist Target AthenaHealth Rise After Q3 ResultsShares of Activist Target AthenaHealth Rise After Q3 Results
finance.yahoo.com - October 21 at 3:54 PM
Shares of Activist Target AthenaHealth Rise After Q3 ResultsShares of Activist Target AthenaHealth Rise After Q3 Results
finance.yahoo.com - October 21 at 3:54 PM
Royal Bank Of Canada Reiterates "$144.00" Price Target for athenahealth, Inc. (ATHN)Royal Bank Of Canada Reiterates "$144.00" Price Target for athenahealth, Inc. (ATHN)
www.americanbankingnews.com - October 21 at 7:10 AM
Investors like athenahealths restructuring plan; shares ahead 11% - Seeking AlphaInvestors like athenahealth's restructuring plan; shares ahead 11% - Seeking Alpha
seekingalpha.com - October 21 at 3:58 AM
Athenahealth Q3 top line up 11%; earnings down 7%; operating income guidance raised; shares down 1% after hours - Seeking AlphaAthenahealth Q3 top line up 11%; earnings down 7%; operating income guidance raised; shares down 1% after hours - Seeking Alpha
seekingalpha.com - October 20 at 10:57 PM
athenahealths (ATHN) CEO Jonathan Bush on Q3 2017 Results ... - Seeking Alphaathenahealth's (ATHN) CEO Jonathan Bush on Q3 2017 Results ... - Seeking Alpha
seekingalpha.com - October 20 at 10:57 PM
Athenahealth Q3 Just A Little Worse Than Expected, Things Could Get Better From Here - BenzingaAthenahealth Q3 Just A Little Worse Than Expected, Things Could Get Better From Here - Benzinga
www.benzinga.com - October 20 at 10:57 PM
athenahealth (ATHN) Beats Earnings, Misses Revenues in Q3 - Nasdaqathenahealth (ATHN) Beats Earnings, Misses Revenues in Q3 - Nasdaq
www.nasdaq.com - October 20 at 10:57 PM
Head to Head Review: athenahealth (ATHN) versus Its PeersHead to Head Review: athenahealth (ATHN) versus Its Peers
www.americanbankingnews.com - October 20 at 10:30 PM

Social Media

Financials

Chart

athenahealth (NASDAQ ATHN) Chart for Friday, November, 24, 2017
Loading chart…

This page was last updated on 11/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.